What Validant does

Validant (legally Kinsale Holdings, Inc. dba Validant, Delaware corporation) is a global regulatory, compliance, and quality consulting firm serving the life sciences industry. Founded in 2005 and headquartered in San Francisco, the company provides strategy, execution, and ongoing support services across the full GxP product lifecycle, including preclinical, clinical, manufacturing, and distribution phases. Its client base spans pharmaceutical, biologics, medical device, diagnostics/IVD, and gene and cell therapy manufacturers, including 25 of the top 30 global medical device firms, 20 of the top 30 global pharma firms, and 7 of the top 10 biotech firms. Services are organized by need (Strategic Consulting, Execution Services, Ongoing Support), by phase (Preclinical, Clinical, Manufacturing, Distribution), and by focus area (Regulatory, Compliance, Quality), with specialized offerings in EU MDR/IVDR compliance and ATMP/gene therapy regulatory pathways.

Validant's core differentiator is its consultant bench, composed of former FDA officials, former regulators from global health agencies, and former industry executives from major pharmaceutical and medical device companies (Boston Scientific, Cardinal Healthcare, Sanofi-Aventis, Novartis, SmithKline Beecham). This talent base provides deep expertise in agency navigation, complex regulatory pathways, and remediation work following warning letters, 483 observations, and consent decrees. Delivery is enabled through a curated global consultant network spanning nearly every major country, allowing rapid team scaling from 1 to 100+ consultants within one week. The company operates five regional hubs (San Francisco, Durham, Boston, Cork, Shanghai) and is GDPR-compliant.

Since December 2018, Validant has been owned by GHO Capital Partners, a European specialist healthcare private equity firm, which has executed an aggressive buy-and-build strategy, acquiring DataRevive (2019), IDEC (2020), Oriel STAT A MATRIX (2021), Greenleaf Health (2021), and RApport Global Strategic Services (2024). These acquired firms, along with Validant, were unified in January 2024 under the single ELIQUENT Life Sciences brand. Revenue is generated through professional services engagements on a quote-based, project and retainer model, with multi-year contracts typical. The company does not operate a software platform or AI-native technology layer; value is delivered through human expertise.

Name

Validant

Legal name

Kinsale Holdings, Inc. dba Validant

Website

https://validant.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Validant is a global regulatory, compliance, and quality consulting firm serving pharmaceutical, biologics, medical device, diagnostics, and gene/cell therapy companies across the full GxP product lifecycle, owned by GHO Capital and operating under the ELIQUENT Life Sciences brand since 2024.

Ownership category

akta.pro rank

Product category

Regulatory Affairs Consulting

akta.pro primary industry

Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA)

akta.pro secondary industries

Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA) (HLAGAKAJ), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Training & Competency Programs for GxP Compliance (HLAGAKAM), Computer System Validation (CSV) & GxP IT Compliance (21 CFR Part 11/Annex 11) (HLAGAKAG)

Keywords

• Regulatory affairs consulting
• Pharmaceutical compliance consulting
• Medical device regulatory
• GxP quality consulting
• Biologics regulatory services

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Regulatory Consulting Services: Professional consulting services spanning the full GxP product lifecycle including preclinical, clinical, manufacturing, and distribution phases. Revenue is generated through project-based engagements and retainer arrangements for ongoing support.
2. Compliance Consulting: Services focused on health authority response, remediation support for consent decrees, warning letters, and 483s. Includes inspection readiness and mock inspections.
3. Quality Consulting: Quality management systems design, implementation, and optimization services including QMS strategy, validation, qualification, and ongoing quality operations support.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Validant provides regulatory, compliance, and quality consulting services to pharmaceutical, biologics, medical device, and diagnostics companies across the full GxP product lifecycle. Services span preclinical, clinical, manufacturing (GMP), and distribution (GDP) phases, delivered through strategic advisory, execution/implementation teams, and ongoing support engagements staffed by former regulators and industry experts.

Product overview

Validant (now operating under ELIQUENT Life Sciences) is a full-service global regulatory, compliance, and quality consulting firm providing strategy, execution, and ongoing support services spanning the entire GxP product lifecycle. The core offerings include Strategic Consulting (regulatory strategy, QMS design, data integrity), Execution Services (talent deployment for implementation), and Ongoing Support (monitoring, training, inspection readiness). Services are organized by phase (Preclinical, Clinical, Manufacturing, Distribution) and focus area (Regulatory, Compliance, Quality). The company serves pharmaceuticals, biologics, medical devices, diagnostics, and gene/cell therapies. Validant has expanded through acquisitions including DataRevive (regulatory strategy), Greenleaf Health (FDA consulting), Oriel STAT A MATRIX (medical device training), IDEC (Japan regulatory), and RApport (European regulatory), all operating under the ELIQUENT Life Sciences umbrella alongside a global consultant network.

Differentiator

Problem solved

Functional benefit

Brands

• ELIQUENT Life Sciences: The unified brand under which the Validant Group of companies operates, combining Validant, Greenleaf Health, DataRevive, Oriel STAT A MATRIX, IDEC, and RApport.

Products and services

• Strategic Consulting
• Execution Services
• Ongoing Support
• Preclinical Consulting
• Clinical Consulting
• Manufacturing GMP Consulting
• Distribution GDP Consulting
• Regulatory Consulting
• Compliance Consulting
• Quality Consulting
• Pharmaceuticals Consulting
• Biologics Consulting
• Medical Device Consulting
• Diagnostics & IVDs Consulting
• Gene & Cell Therapies Consulting
• EU MDR/IVDR Compliance Services
• COVID-19 Response Services
• DataRevive Partner company specializing in regulatory affairs for small molecule and biological products, featuring former FDA CMC and clinical professionals with expertise in expedited pathways.
• Greenleaf Health FDA regulatory consulting firm with team of experts drawing on over 300 years of combined FDA experience, providing strategic guidance to pharmaceutical, biotech, and medical device companies.
• Oriel STAT A MATRIX Global consultancy and training firm for the medical device industry, providing regulatory, quality and compliance consulting along with auditor training, with relationships with 90% of top 10 medical device companies.
• IDEC Leading regulatory consultancy based in Japan, expanding Validant's geographic reach and providing comprehensive Asian regulatory services.
• RApport Global Strategic Services UK-based international regulatory consultancy supporting life science innovators in gaining and maintaining product authorization worldwide, with European regulatory expertise.

Quantifiable outcome

• 100% passing of 32 IND applications over one year for DataRevive client

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core.

• RApport Global Strategic ServicescoreOthers · 23 January 2024UK-based international regulatory consultancy supporting life science innovators gaining and maintaining authorization for products worldwide. Acquisition expands ELIQUENT's European capabilities and geographic reach.
• Greenleaf HealthcoreOthers · 23 April 2021Leading FDA regulatory consulting firm acquired by Validant. Greenleaf provides strategic and technical guidance to pharmaceutical, biotechnology, and medical device companies. Team includes former FDA professionals with over 300 years of combined FDA experience. Headquartered in Washington, D.C.
• Oriel STAT A MATRIXcoreOthers · 15 April 2021Global consultancy and training firm for the medical device industry. Headquartered in New Jersey, Oriel provides regulatory, quality and compliance consulting as well as training. Industry leader with relationships with 90% of top 10 medical device companies globally.
• IDECcoreOthers · 24 November 2020Leading regulatory consultancy based in Japan. Acquired by Validant to expand geographic reach and establish comprehensive Asian regulatory services.
• DataRevivecoreOthers · 1 November 2019Regulatory strategy and consulting business focused on novel therapeutics and biologics. DataRevive's team includes former FDA CMC and clinical professionals providing expertise in expedited pathways including Fast Track, Breakthrough Therapy, and Orphan Drug Designation.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• IQVIA: Global clinical and life sciences services giant offering regulatory and quality consulting alongside its core CRO operations. Comparable to Validant as a large-scale GxP advisory provider, though IQVIA operates across a much broader services portfolio including clinical, commercial, and technology offerings.
• ICON plc: Global CRO with dedicated regulatory and consulting services across pharma and biotech. Comparable to Validant for enterprise-scale regulatory engagements, though ICON's primary business is clinical trial execution rather than specialized regulatory consulting.
• Parexel International: Global CRO offering regulatory consulting, clinical development, and post-market services to biopharma clients. Comparable to Validant in regulatory and quality advisory scope, but at much larger scale and with broader clinical services.
• Syneos Health: Clinical and commercial services organization with regulatory and pharmacovigilance capabilities. Comparable to Validant for GxP advisory work, particularly for pharma and biotech customers, though Syneos is much larger and clinical-trail focused.
• Deloitte (Life Sciences Regulatory practice): Big-4 advisory firm with a dedicated life sciences regulatory and quality practice serving pharma, biotech, and medical device companies. Comparable to Validant for enterprise GxP consulting engagements, but operating at significantly larger scale with broader advisory services.
• Charles River Laboratories: Life sciences research and manufacturing services provider with regulatory and quality consulting adjacencies. Comparable to Validant in serving pharma/biotech regulatory needs, though Charles River's core focus is preclinical and manufacturing rather than regulatory consulting.

Direct peers

• ProPharma Group: Specialized regulatory, compliance, and pharmacovigilance consulting firm serving pharmaceutical, biotech, and medical device companies. Closely comparable to Validant in service mix and target customers, though smaller in scale and without Validant's PE-backed acquisition roll-up.
• PharmaLex (now part of Cencora): Regulatory affairs, pharmacovigilance, and quality consulting firm serving life sciences companies globally. Highly comparable to Validant's ELIQUENT offering across GxP, with similar geographic footprint and customer segments; recently acquired by Cencora.

Emerging players

• Arriello: Regulatory affairs and pharmacovigilance consultancy serving pharma and biotech across Europe, the US, and Asia. Comparable to Validant's regulatory strategy and submission support offerings, though smaller and with a narrower geographic footprint.
• Biopharma Excellence: Specialized regulatory and quality consulting firm serving biopharma, with particular focus on biologics and ATMPs. Comparable to Validant/ELIQUENT in service mix and target customer profile, though operating at a smaller scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/validant
• LinkedInlinkedin.com/company/validant

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Validant